Build an Inve Case for LAES → Read the full call →
SEALSQ (LAES) earnings
SEALSQ earnings: last reported Tue, 15 Sep 2026, for the quarter ended Jun 2026.
SEALSQ earnings callsSEALSQ earnings calls (LAES)
Latest concall · Q2 2026 · call held call held 15 Sept 2026
SEALSQ H1 FY26 — Strong Revenue Growth and Quantum Security Transformation
What went well
- Revenue increased by 131% to $11.2 million in H1 2026 compared to $4.8 million in H1 2025.
- Gross profit increased by 233% to $5.4 million, with gross margin expanding to approximately 48%.
- Achieved NIST SP 800-90B secure source validation (E3333) for QS7001 and FIPS 140-3 validation (#5463) for VaultIC 408.
What to watch
- Operating loss increased to $32.2 million in H1 2026 from $21.2 million in H1 2025.
- Net loss increased to $27.8 million in H1 2026 from $20 million in H1 2025.
Performance −35.9% 1Y
1Y: $3.65 on 29 Sept 2025 → $2.34. High $7.65 (14 Oct 2025), low $2.09 (9 Apr 2026).
Balance sheet
| Year ending | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Equity capital | — | $1.77M | $75.0K | $154.0K | $1.00M | — |
| Reserves | — | -$23.21M | -$17.44M | -$20.71M | -$41.91M | -$76.11M |
| Total liabilities | — | $25.41M | $21.45M | $22.90M | $21.08M | $42.67M |
| Fixed assets | — | $886.0K | $782.0K | $3.23M | $3.20M | $3.77M |
| Investments | — | — | — | — | — | $10.03M |
| Total assets | — | $11.84M | $21.66M | $27.93M | $97.57M | $504.18M |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Insider filings
50 filings between Mar 18, 2026 and Sep 3, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$1.04M
37 sales by 6 insiders
100% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 12
- Option exercise — converted options into shares
- 1
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| O'Hara John Charles | — | $556.9K | Jun 5, 2026 |
| Enguent Jean-Pierre | — | $247.8K | Sep 3, 2026 |
| Moreira Carlos | — | $112.3K | Jun 5, 2026 |
| Buonanno Franck Jean | — | $81.5K | May 14, 2026 |
| Feuardent Moreira Andreas | — | $23.1K | Apr 7, 2026 |
| Verjus Nathalie Claude Odile | — | $15.1K | Mar 18, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 plan | 15,000 | $36.0K |
| Sep 1, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 plan | 15,000 | $150 |
| Aug 5, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 plan | 15,000 | $36.9K |
| Aug 3, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 plan | 15,000 | $150 |
| Jul 8, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 plan | 15,000 | $42.3K |
| Jul 6, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 plan | 15,000 | $150 |
| Jun 16, 2026 | Ward Peter Director | Option exercise | 366,746 | $3.7K |
| Jun 16, 2026 | Ward Peter Director | Tax withheld | 96,530 | $296.3K |
| Jun 5, 2026 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 plan | 300 | $1.1K |
| Jun 5, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 143 | $502 |
| Jun 3, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 plan | 15,000 | $52.7K |
| Jun 3, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 5,582 | $19.7K |
| Jun 3, 2026 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 plan | 7,005 | $24.7K |
| Jun 2, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $36.9K |
| Jun 2, 2026 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 plan | 10,000 | $36.9K |
| Jun 1, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 plan | 15,000 | $150 |
| May 29, 2026 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 plan | 10,000 | $35.1K |
| May 29, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $35.1K |
| May 27, 2026 | Moreira Carlos Chief Executive Officer | Sale 10b5-1 plan | 4,139 | $14.5K |
| May 27, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 4,689 | $16.4K |
| May 14, 2026 | Buonanno Franck Jean Vice-President, Global Sales | Sale 10b5-1 plan | 20,000 | $58.0K |
| May 11, 2026 | Buonanno Franck Jean Vice-President, Global Sales | Option exercise 10b5-1 plan | 20,000 | $200 |
| May 6, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 plan | 15,000 | $47.0K |
| May 4, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 plan | 15,000 | $150 |
| Apr 24, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 5,250 | $15.3K |
| Apr 23, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $28.8K |
| Apr 22, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $30.6K |
| Apr 21, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $30.4K |
| Apr 20, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $27.9K |
| Apr 17, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $27.2K |
| Apr 16, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $26.9K |
| Apr 13, 2026 | O'Hara John Charles Chief Financial Officer | Option exercise 10b5-1 plan | 130,500 | $1.3K |
| Apr 9, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $20.8K |
| Apr 8, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $22.0K |
| Apr 8, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Sale 10b5-1 plan | 15,000 | $33.0K |
| Apr 7, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $21.4K |
| Apr 7, 2026 | Feuardent Moreira Andreas Chief Innovation Officer | Option exercise 10b5-1 plan | 10,000 | $100 |
| Apr 7, 2026 | Feuardent Moreira Andreas Chief Innovation Officer | Sale 10b5-1 plan | 10,000 | $23.1K |
| Apr 6, 2026 | Enguent Jean-Pierre Vice President, R&DSS | Option exercise 10b5-1 plan | 15,000 | $150 |
| Apr 6, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $24.2K |
| Apr 2, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $24.5K |
| Mar 31, 2026 | Buonanno Franck Jean Vice-President, Global Sales | Sale 10b5-1 plan | 10,000 | $23.5K |
| Mar 30, 2026 | O'Hara John Charles Chief Financial Officer | Option exercise 10b5-1 plan | 100,000 | $1.0K |
| Mar 27, 2026 | Buonanno Franck Jean Vice-President, Global Sales | Option exercise | 15,000 | $150 |
| Mar 25, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $29.2K |
| Mar 24, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $29.0K |
| Mar 23, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $29.9K |
| Mar 20, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $30.0K |
| Mar 19, 2026 | O'Hara John Charles Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $30.2K |
| Mar 18, 2026 | Verjus Nathalie Claude Odile Company Secretary | Sale 10b5-1 plan | 5,000 | $15.1K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.